The Zhang laboratory is affiliated with the Department of Pharmacology and Toxicology and the Simon Cancer Center at Indiana University School of Medicine. The major research interest of the Zhang laboratory is on tumorigenesis, drug discovery, and cancer treatment resistance.
The laboratory is housed in the new state of the art Joseph Walther Hall (known as R3) and consists of graduate students, postdoctoral fellows, junior faculty and technical staff. The lab provides an outstanding opportunity for training of summer undergraduate students, graduate students and postdoctoral fellows in the areas of molecular biology, chemical biology, pharmacology, biochemistry, cancer biology, and bio/chemoinformatics.
National Cancer Institute (R01 CA211904)
Title: Translational control in Wnt/β-catenin signaling and colon tumorigenesis
National Cancer Institute/QRKanswer LLC (R41 CA19577)
Title: A novel STAT3 inhibitor targeting its DNA-binding site for drug development
Department of Defense (BC150290)
Title: Targeting FASN for breast cancer treatment by repositioning PPIs
Department of Defense (PC131242)
Title: Targeting survivin to overcome acquired taxol resistance in prostate cancer chemotherapy
A full list of Jian-Ting Zhang, PhD, publication is available on NCBI.